KI
PACB icon

Kula Investments’s Pacific Biosciences PACB Stock Holding History

Kula Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$339K Buy
29,236
+17,194
+143% +$171K 0.08% 426
2022
Q4 		$98.5K Buy
+12,042
New +$104K 0.03% 558

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Kula Investments's PACB Position: Q1 2023 in Review

Kula Investments increased its Pacific Biosciences (PACB) stake by 143% in Q1 2023, buying an estimated $171K and bringing the position to 29,236 shares worth $339K. The position accounts for 0.08% of the portfolio, ranked #426.

Kula Investments first reported a position in PACB in Q4 2022 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold PACB as of Q1 2023.

  • Kula Investments held 29,236 shares of Pacific Biosciences worth $339K as of Q1 2023.
  • Kula Investments bought 17,194 Pacific Biosciences shares in Q1 2023, an estimated $171K.
  • Pacific Biosciences made up 0.08% of Kula Investments's portfolio in Q1 2023, its #426 holding.
  • Kula Investments first reported a position in Pacific Biosciences in Q4 2022 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.